Statins for prevention of hepatocellular cancer: One step closer? (original) (raw)
Are statins a viable option for the treatment of infections with the hepatitis C virus?
Leen Delang
Antiviral Research, 2014
View PDFchevron_right
Effectiveness and Hepatotoxicity of Statins in Men Seropositive for Hepatitis C Virus
David Parra
Pharmacotherapy, 2007
View PDFchevron_right
Chemoprevention for hepatocellular carcinoma: the role of statins
Giuseppe Cabibbo
Hepatobiliary surgery and nutrition, 2013
View PDFchevron_right
Evaluating the Effect of Statins on Prognosis in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
Ho Joong Choi
2021
View PDFchevron_right
Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development
Leen Delang
Hepatology, 2009
View PDFchevron_right
Statin use and risk of hepatocellular carcinoma
Hsueh-chou Lai
European Journal of Epidemiology, 2013
View PDFchevron_right
Statin efficacy in the treatment of hepatitis C genotype I
Mohammad Minakari
2014
View PDFchevron_right
Statin Use is Associated With a Lower Risk of Recurrence After Curative Resection in BCLC Stage 0-a Hepatocellular Carcinoma
Ching-Hui Chuang
View PDFchevron_right
Don’t Judge a Book by Its Cover: The Role of Statins in Liver Cancer
Miroslaw Kornek
Cancers
View PDFchevron_right
Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes
Arnab Basu
Virology, 2006
View PDFchevron_right
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
Masataka Sata
Journal of Experimental Medicine, 2002
View PDFchevron_right
Statins and primary liver cancer
Giovanni Corrao
European Journal of Cancer Prevention, 2013
View PDFchevron_right
STAT3 induces anti-hepatitis C viral activity in liver cells
Haizhen Zhu
Biochemical and Biophysical Research Communications, 2004
View PDFchevron_right
Do statins reduce hepatitis C RNA titers during routine clinical use?
David Kaplan
World Journal of Gastroenterology, 2009
View PDFchevron_right
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
Siddharth Singh
Gastroenterology, 2013
View PDFchevron_right
Oncoprotein Stathmin Modulates Sensitivity to Apoptosis in Hepatocellular Carcinoma Cells During Hepatitis C Viral Replication
Asim Dasgupta
Journal of Cell Death
View PDFchevron_right
Hepatic expression of STAT1, SOCS3 & PIAS1 in HCV Patients and their Role in Response to therapy
Deena Ziada, Sherif Saadany
View PDFchevron_right
SKI-1/S1P inhibition: A promising surrogate to statins to block Hepatitis C virus replication
Nabil G. Seidah
Antiviral Research, 2012
View PDFchevron_right
STAT-C: New therapies cannot get here fast enough
Giuseppe Morelli
Current Hepatitis Reports, 2009
View PDFchevron_right
Statins in liver disease: A molehill, an iceberg, or neither?
Curtis Argo, Amedeo Lonardo
Hepatology, 2008
View PDFchevron_right
Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies
Mohaimenul Islam
Cancers
View PDFchevron_right
Is It Possible To Reduce the Risk of Hepatocellular Carcinoma by Taking Statin in Diabeties Mellitus Patients with HBV or HCV
GUEI-FEN CHIU
Journal of Cancer Science & Therapy, 2017
View PDFchevron_right
The Role of Hepatic Expression of STAT1, SOCS3 and PIAS1 in the Response of Chronic Hepatitis C Patients to Therapy
Dr Dina Ziada
Canadian Journal of Gastroenterology, 2013
View PDFchevron_right
Hepatitis C virus-induced hepatocarcinogenesis
Birke Bartosch
Journal of Hepatology, 2009
View PDFchevron_right
Statin Use and the Risk of Liver Cancer: A Population-Based Case–Control Study
Chih-cheng Chen
American Journal of Gastroenterology, 2010
View PDFchevron_right
Hepatitis C virus-induced hepatocellular carcinoma
Naoya Kato
Clinical and Molecular Hepatology, 2015
View PDFchevron_right
Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies
R. Aldabe
Gut, 2005
View PDFchevron_right
Statins and Reduced Risk of Liver Cancer: Evidence for Confounding: Table 1
Bruce Fireman
Journal of the National Cancer Institute, 2016
View PDFchevron_right
Hepatitis C Virus (HCV) Constitutively Activates STAT-3 via Oxidative Stress: Role of STAT-3 in HCV Replication
James Turkson
Journal of Virology, 2005
View PDFchevron_right
The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients
Shinn-cherng Chen, Wan-long Chuang
Journal of Gastroenterology and Hepatology, 2015
View PDFchevron_right
Hepatitis C virus expression suppresses interferon signaling by degrading STAT1
Yoichi Hiasa
Gastroenterology, 2005
View PDFchevron_right
Hepatitis C virus and hepatocellular carcinoma
Raffaella Romeo
Best Practice & Research Clinical Gastroenterology, 1999
View PDFchevron_right
Impact of direct-acting antivirals on the recurrence of hepatocellular carcinoma in chronic hepatitis C
Hepatoma Research
Hepatoma Research, 2022
View PDFchevron_right
Different statins produce highly divergent changes in gene expression profiles of human hepatoma cells: a pilot study
Roksana Iwanicka-nowicka, Beata Burzynska
Acta biochimica Polonica, 2011
View PDFchevron_right